# HCA Healthcare, Inc.: Form 10-K for the period ended Dec 31, 2021

- Company: [HCA Healthcare, Inc.](/companies/hca.md) (CIK 860730)
- Form: 10-K
- Filed: 2022-02-18
- Accepted by EDGAR: Feb 18, 2022, 17:01 ET
- Period: 2021-12-31
- Accession: 0001193125-22-046707
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/860730/000119312522046707/d32297d10k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/860730/000119312522046707/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2021-01-01 to 2021-12-31 | $58.75bn | us-gaap:Revenues |
| Interest expense | 12 months, 2021-01-01 to 2021-12-31 | $1.57bn | us-gaap:InterestExpense |
| Income tax | 12 months, 2021-01-01 to 2021-12-31 | $2.11bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2021-01-01 to 2021-12-31 | $6.96bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2021-01-01 to 2021-12-31 | $21.16 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2021-01-01 to 2021-12-31 | $21.52 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2021-01-01 to 2021-12-31 | 328,752,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2021-01-01 to 2021-12-31 | $8.96bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2021-01-01 to 2021-12-31 | $3.58bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months, 2021-01-01 to 2021-12-31 | $624.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 12 months, 2021-01-01 to 2021-12-31 | $8.21bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2021-12-31 | $1.45bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-12-31 | $13.54bn | us-gaap:AssetsCurrent |
| Total assets | at 2021-12-31 | $50.74bn | us-gaap:Assets |
| Current liabilities | at 2021-12-31 | $9.58bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2021-12-31 | $34.34bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2021-12-31 | $237.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2021-12-31 | −$933.0m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/860730/000119312522046707/d32297d10k.htm

Filed Feb 18, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-046707. Last ingested by Listed: Nov 11, 2026, 03:15 ET. No prices; not investment advice.
